Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Circulation
|
June 1, 1988
Intracardiac generation of angiotensin and its physiologic role
K Lindpaintner, M Jin, M J Wilhelm, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1989
High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli
R H Becker, U Albus, I Kress, et al.
Arzneimittel-Forschung
|
October 1, 1992
Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate
W Linz, E Klaus, U Albus, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1994
Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency
M Hropot, H Grötsch, E Klaus, et al.
Diabetologia
|
November 18, 2003
The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy
S Schäfer, W Linz, H Vollert, et al.
Basic Research in Cardiology
|
June 1, 1997
Myocardial angiotensin receptor type 1 gene expression in a rat model of cardiac volume overload
P Bauer, V Regitz-Zagrosek, H Kallisch, et al.
European Journal of Pharmacology
|
July 17, 1985
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
J Z Xiang, W Linz, H Becker, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1989
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril
W Linz, B A Schölkens, J Kaiser, et al.
Experimental Physiology
|
June 25, 1998
Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat
R Meyer, K W Linz, R Surges, et al.
Molecular and Cellular Biochemistry
|
June 7, 1995
Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis
W Linz, G Wiemer, J Schaper, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Circulation
|
June 1, 1988
Intracardiac generation of angiotensin and its physiologic role
K Lindpaintner, M Jin, M J Wilhelm, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1989
High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli
R H Becker, U Albus, I Kress, et al.
Arzneimittel-Forschung
|
October 1, 1992
Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate
W Linz, E Klaus, U Albus, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1994
Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency
M Hropot, H Grötsch, E Klaus, et al.
Diabetologia
|
November 18, 2003
The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy
S Schäfer, W Linz, H Vollert, et al.
Basic Research in Cardiology
|
June 1, 1997
Myocardial angiotensin receptor type 1 gene expression in a rat model of cardiac volume overload
P Bauer, V Regitz-Zagrosek, H Kallisch, et al.
European Journal of Pharmacology
|
July 17, 1985
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
J Z Xiang, W Linz, H Becker, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1989
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril
W Linz, B A Schölkens, J Kaiser, et al.
Experimental Physiology
|
June 25, 1998
Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat
R Meyer, K W Linz, R Surges, et al.
Molecular and Cellular Biochemistry
|
June 7, 1995
Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis
W Linz, G Wiemer, J Schaper, et al.
Page
of 11